High refractive index ophthalmic device materials prepared using a post-polymerization cross-linking method
AssigneeAlcon Manufacturing, Ltd.
InventorsAlbert R. LeBoeuf, Douglas C. Schlueter, Joseph I. Weinschenk III
Life of this patent
Estimating the term…
Abstract
Acrylic, high refractive index ophthalmic device materials comprising an aryl acrylic monomer, a first stage polymerization initiator and a second stage cross-linking agent are prepared in a two-stage method. The monomers used to form the ophthalmic device materials do not contain cross-linking agents having more than one unsaturated bond. In the first stage of the method, the materials are polymerized. In the second stage, the materials are cross-linked by exposure to heat.
Claims13
A two-stage method for preparing an acrylic, high refractive index ophthalmic device material, wherein the ophthalmic device material comprises
- (i) at least one aryl acrylic hydrophobic monomer of the formula 2
- wherein:
- X is H or CH3;
- m is0-10;
- Y is nothing, O, S, or NR wherein R is H, CH3, CnH2n+1 (n=1-10) iso OC3H7, C6H5, or CH2C6H5;
- Ar is any aromatic ring which can be unsubstituted or substituted with CH3, C2H5, n-C3H7, iso-C3H7, OCH3, C6H11, Cl, Br, C6H5, or CH2C6H5;
- (ii) a first stage polymerization initiator selected from the group consisting of photoinitiators and thermal free radical initiators having a 10 hr t½ of about 55° C. or less;
- and
- (iii) a second stage cross-linking agent where the second stage cross-linking agent is a thermal free radical initiator having a 10 hr t1/2 of about 50° C. or greater if the first stage polymerization initiator is a photoinitiator and the second stage cross-linking agent is a thermal free radical initiator having a 10 hr t½ of about 65° C. or greater if the first stage polymerization initiator is a thermal free radical initiator having a 10 hr t1/2 of about 55° C. or less, wherein the first stage of the method comprises polymerizing the ophthalmic device material by activating the first stage polymerization initiator without activating the second stage cross-linking agent;
- and the second stage of the method comprises cross-linking the ophthalmic device material by activating the second stage cross-linking agent.
Dependencies are inferred from the claim text.